Breakpoint Therapeutics aims to progress the medical advancement of initial-in-class oncology medication that interfere with DNA fix and replication tension tolerance pathways. The organization’s therapeutics goal the DNA hurt reaction in cancer cells with fix and replication pressure tolerance pathways, enabling the professional medical organisation and hospitals to acquire medications https://is.gd/VVmTMJ